UBS Maintains Neutral on Amgen, Raises Price Target to $238
UBS maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $194 to $238.
Morgan Stanley Maintains Equal-Weight on CMS Energy, Raises Price Target to $67
Morgan Stanley maintains CMS Energy (NYSE:CMS) with a Equal-Weight and raises the price target from $64 to $67.
JP Morgan Initiates Coverage On CubeSmart with Neutral Rating, Announces $32 Price Target
JP Morgan analyst Michael Mueller initiates coverage on CubeSmart (NYSE:CUBE) with a Neutral rating and a $32 price…
Wells Fargo Downgrades Allergan to Equal-Weight, Announces $198 Price Target
Wells Fargo analyst David Maris downgrades Allergan (NYSE:AGN) from Overweight to Equal-Weight and announces $198 price target.
Citigroup Downgrades Estee Lauder Cos to Neutral, Raises Price Target to $230
Citigroup analyst Wendy Nicholson downgrades Estee Lauder Cos (NYSE:EL) from Buy to Neutral and raises the price target…
JMP Securities Initiates Coverage On Cue Biopharma with Market Outperform Rating, Announces $22 Price Target
JMP Securities analyst Reni Benjamin initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Market Outperform rating and a…
Morgan Stanley Initiates Coverage On ACM Research with Overweight Rating, Announces $45 Price Target
Morgan Stanley initiates coverage on ACM Research (NASDAQ:ACMR) with a Overweight rating and a $45 price target.
Needham Upgrades NeoPhotonics to Buy, Announces $11 Price Target
Needham analyst Alex Henderson upgrades NeoPhotonics (NYSE:NPTN) from Hold to Buy and announces $11 price target.
KeyBanc Maintains Overweight on VMware, Raises Price Target to $186
KeyBanc maintains VMware (NYSE:VMW) with a Overweight and raises the price target from $182 to $186.
KeyBanc Maintains Overweight on Cisco Systems, Raises Price Target to $54
KeyBanc maintains Cisco Systems (NASDAQ:CSCO) with a Overweight and raises the price target from $52 to $54.